Hanmi Science Filer Im Jong-hoon and Related Parties Enter 201 Billion Won Premium Stock Sale Agreements… Ownership Shift and Management Influence Analysis
The filer Im Jong-hoon entered into a stock purchase agreement to sell 1,709,788 shares to Now IB22 Fund at 48,000 won per share, a 48% premium over the current market price of 32,450 won.
Related parties including Hong Ji-yoon, Im Seong-yeon, Im Seong-ji, and Im Seong-ah signed agreements to sell 2,437,891 shares to Shin Dong-kook at 48,800 won per share, totaling approximately 201 billion won.
Although the filer's direct holdings remain unchanged, the actual stake will decrease after the settlement dates in August 2026.
The filer aims to influence management, and the complex borrowing structure with multiple pledge loans and repurchase agreements adds financial strain.
[AI Summary]The premium share sales by Hanmi Science's Im family could provide short-term stock price support, but potential management disputes and high leverage pose medium-to-long-term risks. The unclear use of sale proceeds warrants cautious investor monitoring.